MAPK8 and neoplasm: Because SP600125 increased the proliferation of NEU PKR+/+ cells to the levels identical with those of NEU PKR−/− cells (Fig. 4d), the data suggested that phosphorylated JNK1/2 mediates the anti-proliferative effects of PKR in mouse NEU tumor cells.